BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34448933)

  • 21. The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid-low rectal cancer in obese patients: outcomes of a multicenter propensity-matched analysis.
    Tejedor P; Arredondo J; Simó V; Zorrilla J; Baixauli J; Jiménez LM; Pastor C
    Updates Surg; 2023 Dec; 75(8):2191-2200. PubMed ID: 37903996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.
    Munini M; Popeskou SG; Galetti K; Roesel R; Mongelli F; Christoforidis D
    Int J Colorectal Dis; 2021 Oct; 36(10):2271-2279. PubMed ID: 34467413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local Recurrence and Disease-Free Survival After Transanal Total Mesorectal Excision: Results From the International TaTME Registry.
    Roodbeen SX; Penna M; van Dieren S; Moran B; Tekkis P; Tanis PJ; Hompes R;
    J Natl Compr Canc Netw; 2021 Aug; 19(11):1232-1240. PubMed ID: 34404028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transanal Total Mesorectal Excision With Delayed Coloanal Anastomosis (TaTME-DCAA) Versus Laparoscopic Total Mesorectal Excision (LTME) and Robotic Total Mesorectal Excision (RTME) for Low Rectal Cancer: A Propensity Score-Matched Analysis of Short-term Outcomes, Bowel Function, and Cost.
    Seow-En I; Wu J; Tan IE; Zhao Y; Seah AWM; Wee IJY; Ying-Ru Ng Y; Kwong-Wei Tan E
    Surg Laparosc Endosc Percutan Tech; 2024 Feb; 34(1):54-61. PubMed ID: 37987634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transanal total mesorectal excision for patients with rectal cancer : a Systematic review and meta-analysis.
    Ziati J; Souadka A; Benkabbou A; Boutayeb S; Ahmadi B; Amrani L; Mohsine R; Anass Majbar M
    Gulf J Oncolog; 2021 Jan; 1(35):66-76. PubMed ID: 33716215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of transanal total mesorectal excision for patients with middle and low rectal cancer: A systematic review and meta-analysis.
    Hu D; Jin P; Hu L; Liu W; Zhang W; Guo T; Yang X
    Medicine (Baltimore); 2018 Jul; 97(28):e11410. PubMed ID: 29995787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.
    Robertson RL; Karimuddin A; Phang T; Raval M; Brown C
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision.
    Rubinkiewicz M; Zarzycki P; Witowski J; Pisarska M; Gajewska N; Torbicz G; Nowakowski M; Major P; Budzyński A; Pędziwiatr M
    BMC Surg; 2019 Jul; 19(1):79. PubMed ID: 31277628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transanal total mesorectal excision versus laparoscopic intersphincteric resection for low rectal cancer: a propensity score matching analysis.
    Li Z; Wang Q; Ning W; Yang Q; Huang Y; Yan S; Yang B; Xie M
    Surg Endosc; 2023 Sep; 37(9):6852-6860. PubMed ID: 37308763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis.
    de Lacy FB; Roodbeen SX; Ríos J; van Laarhoven J; Otero-Piñeiro A; Bravo R; Visser T; van Poppel R; Valverde S; Hompes R; Sietses C; Castells A; Bemelman WA; Tanis PJ; Lacy AM
    BMC Cancer; 2020 Jul; 20(1):677. PubMed ID: 32689968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision.
    Chang TC; Kiu KT
    J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):365-369. PubMed ID: 29190178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short Term Postoperative and Oncological Outcomes of Two-Dimensional Versus Three-Dimensional Laparoscopic Transanal Total Mesorectal Excision of Rectal Cancer.
    Tey HTV; Foo SMJ; Fong SS; Chong CS
    J Laparoendosc Adv Surg Tech A; 2020 Dec; 30(12):1350-1353. PubMed ID: 32522084
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.
    Xu W; Xu Z; Cheng H; Ying J; Cheng F; Xu W; Cao J; Luo J
    Eur J Surg Oncol; 2016 Dec; 42(12):1841-1850. PubMed ID: 27697315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
    Hol JC; Burghgraef TA; Rutgers MLW; Crolla RMPH; van Geloven NAW; Hompes R; Leijtens JWA; Polat F; Pronk A; Smits AB; Tuynman JB; Verdaasdonk EGG; Consten ECJ; Sietses C
    Br J Surg; 2021 Nov; 108(11):1380-1387. PubMed ID: 34370834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transanal versus laparoscopic total mesorectal excision: a comparative study of long-term oncological outcomes.
    Ourô S; Ferreira M; Roquete P; Maio R
    Tech Coloproctol; 2022 Apr; 26(4):279-290. PubMed ID: 35050434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes.
    Lin D; Yu Z; Chen W; Hu J; Huang X; He Z; Zou YF; Yu X; Guo X; Wu XJ
    Wideochir Inne Tech Maloinwazyjne; 2019 Sep; 14(3):353-365. PubMed ID: 31534564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.